tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mollison KW et al. | Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat models. | 1998 | Toxicology | pmid:9570331 |
| Araki T et al. | Post-ischemic alterations in [3H]FK506 binding in the gerbil and rat brains. | 1998 | Metab Brain Dis | pmid:9570636 |
| Finney NS | Enantioselective epoxide hydrolysis: catalysis involving microbes, mammals and metals. | 1998 | Chem. Biol. | pmid:9571210 |
| Matsuda T et al. | Involvement of calcineurin in Ca2+ paradox-like injury of cultured rat astrocytes. | 1998 | J. Neurochem. | pmid:9572286 |
| Barinaga M | Signaling path may lead to better heart-failure therapies. | 1998 | Science | pmid:9575084 |
| Miyasaka N | [Recent findings on etiological mechanism of autoimmune diseases]. | 1998 | Nippon Naika Gakkai Zasshi | pmid:9577564 |
| Sakane T | [Physiopathology and therapy of Behcet's syndrome]. | 1998 | Nippon Naika Gakkai Zasshi | pmid:9577569 |
| Sugi-Ikai N et al. | Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. | 1998 | Invest. Ophthalmol. Vis. Sci. | pmid:9579479 |
| Cardoso CM et al. | Uncoupling of Ca2+ transport ATPase in muscle and blood platelets by diacylglycerol analogues and cyclosporin A antagonism. | 1997 | Biochem. J. | pmid:9581558 |
| Abu-Elmagd K et al. | Clinical intestinal transplantation: new perspectives and immunologic considerations. | 1998 | J. Am. Coll. Surg. | pmid:9583691 |
| Zervos XA et al. | Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. | 1998 | Transplantation | pmid:9583863 |
| Muraki T et al. | Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. | 1998 | Transplantation | pmid:9583878 |
| Kadry Z et al. | Kaposi's sarcoma in liver transplant recipients on FK506. | 1998 | Transplantation | pmid:9583882 |
| Chiba K et al. | FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. | 1998 | J. Immunol. | pmid:9590253 |
| Hebebrand D et al. | Limb xenotransplantation using FK506 and RS61443 immunosuppression. | 1998 | J Reconstr Microsurg | pmid:9590615 |
| Wakita H et al. | Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. | 1998 | Brain Res. | pmid:9593846 |
| Marone G et al. | Immunopharmacology of human mast cells and basophils. | 1998 | Int. J. Clin. Lab. Res. | pmid:9594358 |
| Weis M et al. | Impact of immunosuppression on coronary endothelial function after cardiac transplantation. | 1998 | Transplant. Proc. | pmid:9595131 |
| Gregory CR | Immunosuppressive approaches to the prevention of graft vascular disease. | 1998 | Transplant. Proc. | pmid:9595134 |
| Koyama T et al. | [Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation]. | 1998 | Jpn J Antibiot | pmid:9597507 |
| Wagner R et al. | 32-Ascomycinyloxyacetic acid derived immunosuppressants. Independence of immunophilin binding and immunosuppressive potency. | 1998 | J. Med. Chem. | pmid:9599228 |
| Hueros G et al. | A maize FK506-sensitive immunophilin, mzFKBP-66, is a peptidylproline cis-trans-isomerase that interacts with calmodulin and a 36-kDa cytoplasmic protein. | 1998 | Planta | pmid:9599809 |
| Oyanagui Y | Immunosuppressants enhance superoxide radical/nitric oxide-dependent dexamethasone suppression of ischemic paw edema in mice. | 1998 | Eur. J. Pharmacol. | pmid:9600660 |
| Jurcevic S et al. | A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. | 1998 | Transplantation | pmid:9603168 |
| Beatty PR et al. | Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. | 1998 | Transplantation | pmid:9603175 |
| Shapiro R et al. | Alopecia as a consequence of tacrolimus therapy. | 1998 | Transplantation | pmid:9603186 |
| Capone D et al. | Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients. | 1998 | J Chemother | pmid:9603651 |
| Chang RK et al. | Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. | 1998 | Am. J. Cardiol. | pmid:9604971 |
| Homey B et al. | Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. | 1998 | J. Immunol. | pmid:9605132 |
| Tomura N et al. | Transient neurotoxicity associated with FK506: MR findings. | 1998 May-Jun | J Comput Assist Tomogr | pmid:9606397 |
| Tomono M et al. | Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. | 1998 | Arch. Biochem. Biophys. | pmid:9606972 |
| Singer NG and McCune WJ | Update on immunosuppressive therapy. | 1998 | Curr Opin Rheumatol | pmid:9608317 |
| Ito H et al. | Myoblast transplantation in non-dystrophic dog. | 1998 | Neuromuscul. Disord. | pmid:9608563 |
| Kliem V and Brunkhorst R | Tacrolimus in kidney transplantation. A clinical review. | 1998 | Nephron | pmid:9609456 |
| Samsó M and Wagenknecht T | Contributions of electron microscopy and single-particle techniques to the determination of the ryanodine receptor three-dimensional structure. | 1998 | J. Struct. Biol. | pmid:9615436 |
| Tomás ML | [Immunosuppressive agents: side effects]. | 1997 | An R Acad Nac Med (Madr) | pmid:9616947 |
| Idilman R et al. | Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. | 1998 | Eur J Gastroenterol Hepatol | pmid:9619393 |
| Kikuchi M et al. | Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture. | 1998 | Invest. Ophthalmol. Vis. Sci. | pmid:9620083 |
| Lampen A et al. | Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. | 1998 | Xenobiotica | pmid:9622846 |
| Schulman SL et al. | Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. | 1998 | Transplantation | pmid:9625026 |
| Pruvot FR and Noel C | Comment on "Pregnancy after liver transplantation under tacrolimus" by Jain et al. | 1998 | Transplantation | pmid:9625033 |
| Takada Y et al. | Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. | 1998 | Surgery | pmid:9626320 |
| Ellouk-Achard S et al. | FK506 (Tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction. | 1998 | Arch. Toxicol. | pmid:9630010 |
| Starzl TE et al. | Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. | 1998 | Am. J. Kidney Dis. | pmid:9631858 |
| Al-Awwa IA et al. | Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. | 1998 | Am. J. Kidney Dis. | pmid:9631859 |
| Tredger JM et al. | Therapeutic monitoring of tacrolimus (FK506) with the first- and second-generation microparticle enzyme immunoassays: performance and results in four patient populations. | 1998 | Ther Drug Monit | pmid:9631923 |
| Nicholson ML et al. | Is TGF-beta a profibrotic cytokine in human renal transplants? | 1998 | Transplant. Proc. | pmid:9636384 |
| Ginevri F et al. | Expression of collagen by renal fibroblasts treated with FK 506 in vitro. | 1998 | Transplant. Proc. | pmid:9636387 |
| Hutchinson IV et al. | Differences in the mode of action of cyclosporine and FK 506. | 1998 | Transplant. Proc. | pmid:9636388 |
| Müller V et al. | Effect of mycophenolate mofetil on the in vivo infiltration of lymphocytes in the rat remnant kidney. | 1998 | Transplant. Proc. | pmid:9636396 |